Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Grawunder, Ulf. (Editor ), Barth, Stefan. (Editor )
Formato: eBook
Lenguaje:English
Publicado: Cham : Springer International Publishing : Imprint: Springer, 2017.
Edición:1st ed. 2017.
Colección:Milestones in Drug Therapy,
Materias:
Pharmacology.
Antibodies.
Pharmacotherapy.
Cancer research.
Oncology  .
Pharmacology/Toxicology.
Cancer Research.
Oncology.
Acceso en línea:https://doi.org/10.1007/978-3-319-46877-8
LEADER 01942nam a22003975i 4500
001 978-3-319-46877-8
005 20191026101200.0
007 cr nn 008mamaa
008 170407s2017 gw | s |||| 0|eng d
020 |a 9783319468778 
024 7 |a 10.1007/978-3-319-46877-8  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins  |c edited by Ulf Grawunder, Stefan Barth. 
250 |a 1st ed. 2017. 
260 # # |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a XI, 181 p. 57 illus., 39 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Milestones in Drug Therapy, 
505 0 |a Chemical Assembly of Antibody-Drug Conjugates -- Pre-clinical evaluation of ADCs delivering highly potent pyrrolobenzodiazepine (PBD) dimers -- Stable and homogeneous drug conjugation by sequential bis-alkylation at disulfide bonds using bis-sulfone reagents -- Calicheamicin antibody-drug conjugates for liquid- and solid tumor indications -- Enzyme-based strategies to generate site-specifically conjugated Antibody Drug Conjugates -- Substance P – Saporin for the Treatment of Intractable Pain -- Recombinant immunotoxins for Chronic Inflammatory Disease -- BL22: A milestone in targeting CD22. 
650 0 |a Pharmacology. 
650 0 |a Antibodies. 
650 0 |a Pharmacotherapy. 
650 0 |a Cancer research. 
650 0 |a Oncology  . 
650 1 4 |a Pharmacology/Toxicology. 
650 2 4 |a Antibodies. 
650 2 4 |a Pharmacotherapy. 
650 2 4 |a Cancer Research. 
650 2 4 |a Oncology. 
700 1 |a Grawunder, Ulf.  |e editor. 
700 1 |a Barth, Stefan.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
856 4 0 |u https://doi.org/10.1007/978-3-319-46877-8 

Ejemplares similares